Evidence map›Paper›PMID 29030332›Full record

ArticleClinical cancer research : an official journal of the American Association for Cancer Research2017

Genomics of Immunotherapy-Associated Hyperprogressors-Letter.

Andrea Forschner, Heike Niessner, Yvonne Möller, Peter Horak, Martina Fröhlich, Gregor Warsow, Albrecht Stenzinger, Stefan Fröhling, Hanno Glimm, Bernhard Klumpp and 2 more

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Clinical cancer research : an official journal of the American Association for Cancer Research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Andrea ForschnerDepartment of Dermatology, University Hospital, Tuebingen, Germany. andrea.forschner@med.uni-tuebingen.de.
Heike NiessnerDepartment of Dermatology, University Hospital, Tuebingen, Germany.
Yvonne MöllerCenter for Personalised Medicine, University Hospital, Tuebingen, Germany.
Peter HorakDepartment of Translational Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Section for Personalized Oncology, NCT Heidelberg and Heidelberg University Hospital, Heidelberg, Germany.
Martina FröhlichGerman Cancer Consortium (DKTK), Heidelberg, Germany.
Gregor WarsowDivision of Theoretical Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Albrecht StenzingerInstitute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
Stefan FröhlingDepartment of Translational Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Section for Personalized Oncology, NCT Heidelberg and Heidelberg University Hospital, Heidelberg, Germany.
Hanno GlimmDepartment of Translational Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Section for Personalized Oncology, NCT Heidelberg and Heidelberg University Hospital, Heidelberg, Germany.
Bernhard KlumppDepartment of Radiology, University Hospital, Tuebingen, Germany.
Claus GarbeDepartment of Dermatology, University Hospital, Tuebingen, Germany.
Tobias SinnbergDepartment of Dermatology, University Hospital, Tuebingen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Immunologic FactorsImmunotherapyGenomicsImmunologic Factors

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.